Four-year-old Jakub from Hull and three-year-old Rufus from Bridlington are at increased risk of serious chest infections ...
Following internal analysis and Data Monitoring Committee (DMC) feedback, the Company has elected to discontinue the BX004 ...
Long-term use of the triple-drug therapy allows many individuals with cystic fibrosis to maintain stable health even after ...
A new multi-site study led by researchers at CU Anschutz shows that people with cystic fibrosis (CF) who start the ...
Researchers have found in a new study that triple CFTR modulator therapy, or elexacaftor/tezacaftor/ivacaftor (ETI), produces ...
The Hydrocolloid Science Explained Pimple patches look simple, but they’re backed by solid science. Most are made from ...
Therapeutics Market Size accelerated to USD 10.60 billion in 2024, up from USD 9.22 billion in 2023, and is now projected to expand aggressively to USD 35.09 billion by 2033, recording a CAGR of 14.2% ...
Non-Cystic Fibrosis Bronchiectasis Treatment Market to Reach USD 3.5 Bn by 2035 at 5.8% CAGR, Driven by rising disease burden ...
Surviving breast cancer heightens awareness of bodily changes, with new symptoms potentially triggering fears of recurrence.
Maryam Suleiman developed a life-threatening infection affecting the bones of her skull ...